| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00005792-199907000-00001 |
| P698 | PubMed publication ID | 10424203 |
| P50 | author | Jean-Charles Piette | Q73305204 |
| P2093 | author name string | Biousse V | |
| Wechsler B | |||
| Francès C | |||
| Papo T | |||
| Laporte JL | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Sneddon syndrome | Q684840 |
| antibody | Q79460 | ||
| P304 | page(s) | 209-219 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients | |
| P478 | volume | 78 |
| Q38030580 | A review of pediatric vasculitis with a focus on juvenile polyarteritis nodosa |
| Q33384580 | Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis |
| Q64046338 | Antiphospholipid syndrome |
| Q43599871 | Cerebral glucose metabolism in Sneddon's syndrome associated with antiphospholipid antibodies. |
| Q37778646 | Dermatological manifestations of Hughes’ antiphospholipid antibody syndrome |
| Q30410263 | Early-onset stroke and vasculopathy associated with mutations in ADA2 |
| Q47890518 | Factor V Leiden mutation in Sneddon syndrome |
| Q30955669 | Familial inflammatory Sneddon's syndrome-case report and review of the literature |
| Q37251490 | Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association |
| Q37274431 | Hematological diseases and stroke |
| Q74456594 | Hughes (antiphospholipid) syndrome. Clinical features |
| Q31101744 | Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies? |
| Q50694032 | Improvement of neurological symptoms and memory and emotional status in a case of seronegative Sneddon syndrome with cyclophosphamide. |
| Q30794356 | Intracerebral hemorrhage associated with Sneddon's syndrome: is ischemia-related angiogenesis the cause? Case report and review of the literature |
| Q83348539 | Livedo reticularis and related disorders |
| Q33376910 | Livedo reticularis as a criterion for antiphospholipid syndrome |
| Q26779125 | Livedo reticularis: A review of the literature |
| Q57298140 | Long-term follow-up of early-onset Sneddon syndrome: A case report |
| Q58854434 | Lymphomes malins et syndrome des antiphospholipides non simultanés : quatre observations |
| Q37662228 | Microembolic signals in systemic lupus erythematosus and other cerebral small vessel diseases |
| Q61841825 | Miscarriage, peripheral thromboses and aortic aneurysm in antiphospholipid-antibody-negative Sneddon's syndrome |
| Q34317751 | Neurologic manifestations of the antiphospholipid syndrome. |
| Q53096115 | Neurological presentations of the antiphospholipid syndrome: three illustrative cases. |
| Q41937059 | Primary antiphospholipid syndrome with and without Sneddon's syndrome |
| Q48026341 | Psychosis with suicide attempt in Sneddon syndrome |
| Q92891459 | Role of adenosine deaminase 2 gene variants in pediatric deficiency of adenosine deaminase 2: A structural biological approach |
| Q92835110 | Sneddon Syndrome: A Case Report Exploring the Current Challenges Faced with Diagnosis and Management |
| Q89450543 | Sneddon syndrome and non-bacterial thrombotic endocarditis: a clinicopathological study |
| Q28196612 | Sneddon syndrome revealing dysfibrinogenemia |
| Q36260331 | Sneddon's syndrome presenting with severe disabling bilateral headache. |
| Q34998203 | Sneddon's syndrome: a comprehensive review of the literature |
| Q36393908 | Sneddon's syndrome: another migraine-stroke association? |
| Q38050939 | Sneddon's syndrome: case report and review of its relationship with antiphospholipid syndrome. |
| Q38844621 | Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment |
| Q41516486 | Strokes in Sneddon syndrome without antiphospholipid antibodies |
| Q33394044 | Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations |
| Q28072610 | The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus |
| Q34560515 | The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review |
| Q48035289 | Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy? |
| Q73672348 | [Aspirin and antiphospholipid syndrome] |
| Q82958664 | [Diagnosis and treatment of livedo reticularis on the legs] |
| Q81363461 | [Livedo in adults] |
| Q73092895 | [Pseudovasculitic syndromes] |
| Q81352217 | [Sneddon syndrome with anti-mitochondrial type M5 antibodies] |
| Q54117252 | [Sneddon's syndrome: 15 cases with cerebral angiography] |
| Q80917530 | [The significance and treatment of antiphospholipid antibodies] |
Search more.